Abstract: A display device includes a first barrier insulating layer on a first substrate and including a first contact hole, a pad having a portion on the first barrier insulating layer and another portion inserted into the first contact hole, a second barrier insulating layer including a first portion on an upper surface of the portion of the pad and a second portion on an upper surface of the another portion of the pad, a third barrier insulating layer on the second portion of the second barrier insulating layer, a coating layer on the third barrier insulating layer, a second substrate on the coating layer and the first portion of the second barrier insulating layer, a first connection line on the second substrate and electrically connected to the pad, and a flexible film including a lead electrode inserted into an open part of the first substrate.

Abstract: Provided are a method for administering a recombinant human growth hormone GX-H9 for treating growth hormone deficiency and a pharmaceutical composition containing a recombinant human growth hormone GX-H9 and a pharmaceutically acceptable carrier. The method includes administering recombinant human growth hormone GX-H9 once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient.

Abstract: Various aspects of the present disclosure provide a semiconductor device, for example comprising a finger print sensor, and a method for manufacturing thereof. Various aspects of the present disclosure may, for example, provide an ultra-slim finger print sensor having a thickness of 500 ?m or less that does not include a separate printed circuit board (PCB), and a method for manufacturing thereof.

Abstract: Disclosed is a novel peptide, which is a highly functional peptide derived from a natural fermentation product exhibiting an anti-wrinkle activity. A tetrapeptide consists of an amino acid sequence of glycine (Gly)-glutamine (Gln)-valine (Val)-serine (Ser) (SEQ ID NO: 1). The peptide is synthesized by utilizing 2-(4-nitrophenyl) sulfonylethoxycarbonyl-amino acid (Nsc-amino acid) as an intermediate. The anti-wrinkle activity is exhibited through the inhibition of elastase. The anti-wrinkle activity is exhibited through collagen synthesis. A method of preventing skin wrinkle, includes applying to a skin a tetrapeptide consisting of an amino acid sequence GQVS (SEQ ID NO: 1).

Abstract: There is provided a method of synthesizing the tetrapeptide exhibiting an anti-wrinkle activity consisting of the amino acid sequence of glycine(Gly)-glutamine(Gln)-valine(Val)-serine(Ser) (SEQ ID NO: 1). The method includes: preparing a peptidyl resin by utilizing 2-(4-nitrophenyl) sulfonylethoxycarbonyl-amino acid (Nsc-amino acid); adding an eluting solution to the prepared resin; and filtering the resin and obtaining the tetrapeptide.

Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating an inflammatory disease, comprising a benzofuran-based N-acylhydrazone compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The benzofuran-based N-acylhydrazone compound according to the present disclosure inhibits the activity of NF-?B, which is a major signal transmitter in the inflammatory response, thereby disrupting the initial pathway and process of the biological inflammatory response system and inhibiting inflammatory immune cells and inflammatory cytokines, and thus can prevent and treat various pathological diseases caused by the inflammatory response.

Abstract: Disclosed is a novel peptide, which is a highly functional peptide derived from a natural fermentation product exhibiting an anti-wrinkle activity. A tetrapeptide consists of an amino acid sequence of glycine (Gly)-glutamine (Gln)-valine (Val)-serine (Ser) (SEQ ID NO: 1). The peptide is synthesized by utilizing 2-(4-nitrophenyl)sulfonylethoxycarbonyl-amino acid (Nsc-amino acid) as an intermediate. The anti-wrinkle activity is exhibited through the inhibition of elastase. The anti-wrinkle activity is exhibited through collagen synthesis.

Abstract: A method and system for searching for a route using road-shoulder parking state information is provided for a vehicle operating in conjunction with a server via a wireless communication network. The method includes identifying vehicles stopped on a shoulder of a road by analyzing an image captured by a camera and determining a vehicle to be reported as being stopped on the shoulder of the road among the identified vehicles stopped on the shoulder of the road. A road-shoulder stop report message is generated corresponding to the determined vehicle to be reported as being stopped on the shoulder of the road and the road-shoulder stop report message is transmitted to the server.

Abstract: A vehicle and method of platooning control therefor are provided to achieve optimum communication charge efficiency while a plurality of vehicles perform platooning. A data communication method of a platooning vehicle includes starting platooning by a plurality of vehicles and sharing data charge rate information through a first protocol for vehicle-to-vehicle communication (V2V) by the plurality of vehicles. A first master vehicle and at least one slave vehicle are determined based on the shared data charge rate information. An access point (AP) is then activated according to a second protocol for short distance communication by the first master vehicle and an AP of the master vehicle is accessed and data communication is performed by the at least one slave vehicle.

Abstract: The present disclosure relates to a marker for diagnosing neurodegenerative diseases, and a use thereof, and, more particularly, to: a marker composition for diagnosing neurodegenerative diseases; a composition for diagnosing neurodegenerative diseases, containing a preparation for measuring the glutathionylation level of a FUS protein; a kit for diagnosing neurodegenerative diseases, containing the composition; and an information providing method for diagnosing neurodegenerative diseases by using same. The inventors have discovered that a glutathionylated FUS protein functions as a marker for diagnosing neurodegenerative diseases, and thus a composition for diagnosing neurodegenerative diseases, according to the present disclosure, is expected to contribute to early diagnosis of patients with neurodegenerative diseases.

Abstract: A method and system for searching for a route using road-shoulder parking state information is provided for a vehicle operating in conjunction with a server via a wireless communication network. The method includes identifying vehicles stopped on a shoulder of a road by analyzing an image captured by a camera and determining a vehicle to be reported as being stopped on the shoulder of the road among the identified vehicles stopped on the shoulder of the road. A road-shoulder stop report message is generated corresponding to the determined vehicle to be reported as being stopped on the shoulder of the road and the road-shoulder stop report message is transmitted to the server.

Abstract: A vehicle and method of platooning control therefor are provided to achieve optimum communication charge efficiency while a plurality of vehicles perform platooning. A data communication method of a platooning vehicle includes starting platooning by a plurality of vehicles and sharing data charge rate information through a first protocol for vehicle-to-vehicle communication (V2V) by the plurality of vehicles. A first master vehicle and at least one slave vehicle are determined based on the shared data charge rate information. An access point (AP) is then activated according to a second protocol for short distance communication by the first master vehicle and an AP of the master vehicle is accessed and data communication is performed by the at least one slave vehicle.

Abstract: A system for controlling a vehicle actuated signal includes: a vehicle terminal that transmits actuated signal light information and estimated arrival time information when an actuated signal lane on a travel route is reserved to be used; a telematics server that requests a signal change reservation based on the actuated signal light information and the estimated arrival time information; and a traffic light control server that sets the signal change reservation in response to a request of the telematics server and controls a signal of the actuated signal light based on set reservation information.

Abstract: A private network service providing method and system for breaking dependency on a terminal and providing a private network service is provided.

Abstract: A skin whitening method including: administering to a subject a cosmetic composition including a tranexamic acid-peptide having skin whitening activity selected from the group consisting of Tranexamil-AS, Tranexamil-AT, Tranexamil-AP, Tranexamil-GP, Tranexamil-ES, Tranexamil-KK, Tranexamil-HK, Tranexamil-MY, Tranexamil-GH, Tranexamil-MA, Tranexamil-AH, Tranexamil-CC, Tranexamil-SA, Tranexamil-WA, Tranexamil-WE, Tranexamil-KD, Tranexamil-NA, Tranexamil-TS, Tranexamil-SS, Tranexamil-EC, Tranexamil-TA, Tranexamil-PF, Tranexamil-VS, Tranexamil-VV, Tranexamil-VP, Tranexamil-AA, Tranexamil-PS, Tranexamil-HA, Tranexamil-GK, Tranexamil-KV, Tranexamil-AR, Tranexamil-RP, Tranexamil-PQ, Tranexamil-QG, Tranexamil-PP, Tranexamil-VR, Tranexamil-SV, Tranexamil-ET, Tranexamil-CG and Tranexamil-NT.

Abstract: A skin whitening method including: administering to a subject a cosmetic composition including a tranexamic acid-peptide having skin whitening activity selected from the group consisting of Tranexamil-AS, Tranexamil-AT, Tranexamil-AP, Tranexamil-GP, Tranexamil-ES, Tranexamil-KK, Tranexamil-HK, Tranexamil-MY, Tranexamil-GH, Tranexamil-MA, Tranexamil-AH, Tranexamil-CC, Tranexamil-SA, Tranexamil-WA, Tranexamil-WE, Tranexamil-KD, Tranexamil-NA, Tranexamil-TS, Tranexamil-SS, Tranexamil-EC, Tranexamil-TA, Tranexamil-PF, Tranexamil-VS, Tranexamil-VV, Tranexamil-VP, Tranexamil-AA, Tranexamil-PS, Tranexamil-HA, Tranexamil-GK, Tranexamil-KV, Tranexamil-AR, Tranexamil-RP, Tranexamil-PQ, Tranexamil-QG, Tranexamil-PP, Tranexamil-VR, Tranexamil-SV, Tranexamil-ET, Tranexamil-CG and Tranexamil-NT.

Abstract: A system for controlling a vehicle actuated signal includes: a vehicle terminal that transmits actuated signal light information and estimated arrival time information when an actuated signal lane on a travel route is reserved to be used; a telematics server that requests a signal change reservation based on the actuated signal light information and the estimated arrival time information; and a traffic light control server that sets the signal change reservation in response to a request of the telematics server and controls a signal of the actuated signal light based on set reservation information.

Abstract: The present invention relates to a composition for preventing or treating renal diseases. The composition of the present invention improves lipid metabolism, prevents histological damage including renal fibrosis, alleviates microalbuminuria, and maintains nephrons of renal glomeruli. Therefore, the composition is useful for treating renal diseases.

Abstract: A private network service providing method and system for breaking dependency on a terminal and providing a private network service is provided.

Abstract: The present invention relates to a composition for preventing or treating renal diseases. The composition of the present invention improves lipid metabolism, prevents histological damage including renal fibrosis, alleviates microalbuminuria, and maintains nephrons of renal glomeruli. Therefore, the composition is useful for treating renal diseases.